A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine. (January 2015)
- Record Type:
- Journal Article
- Title:
- A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine. (January 2015)
- Main Title:
- A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine
- Authors:
- Eskandari, Mohammad Reza
Moghaddam, Faezeh
Shahraki, Jafar
Pourahmad, Jalal - Abstract:
- <abstract> <title>Abstract</title> <p>1. 5-Fluorouracil (5-FU) and its prodrug capecitabine are key chemotherapeutic agents in the treatment of many gastrointestinal tract adenocarcinomas. In addition to their beneficial antitumor effects, they also possess undesired cardiac toxicity. In the present study, we investigated the cytotoxic mechanisms of 5-FU and capecitabine in freshly isolated rat cardiomyocytes.</p> <p>2. 5-FU and capecitabine cytotoxicities were associated with reactive oxygen species (ROS) formation, lipid peroxidation and rapid glutathione depletion. Increased intracellular ROS could target mitochondria, and our findings confirmed that the cardiomyocytes mitochondrial membrane potential (ΔΨm) was rapidly decreased by 5-FU and capecitabine. Mitochondrial dysfunction subsequently initiates downstream events that trigger caspase-3 activation, and our results showed that 5-FU and capecitabine activated caspase-3 which leads to apoptosis or necrosis. However, 5-FU acted much more powerful than capecitabine at inducing several cytotoxicity markers in heart cardiomyocytes. In addition, 5-FU but not capecitabine caused lysosomal membrane leakiness when it was incubated with cardiomyocytes. All cytotoxicity markers were prevented by antioxidants, ROS scavengers, mitochondrial permeability transition (MPT) pore sealing agents and lysosomotropic agents.</p> <p>3. Our findings showed that the cytotoxic action of 5-FU and capecitabine on cardiomyocytes are mediated by<abstract> <title>Abstract</title> <p>1. 5-Fluorouracil (5-FU) and its prodrug capecitabine are key chemotherapeutic agents in the treatment of many gastrointestinal tract adenocarcinomas. In addition to their beneficial antitumor effects, they also possess undesired cardiac toxicity. In the present study, we investigated the cytotoxic mechanisms of 5-FU and capecitabine in freshly isolated rat cardiomyocytes.</p> <p>2. 5-FU and capecitabine cytotoxicities were associated with reactive oxygen species (ROS) formation, lipid peroxidation and rapid glutathione depletion. Increased intracellular ROS could target mitochondria, and our findings confirmed that the cardiomyocytes mitochondrial membrane potential (ΔΨm) was rapidly decreased by 5-FU and capecitabine. Mitochondrial dysfunction subsequently initiates downstream events that trigger caspase-3 activation, and our results showed that 5-FU and capecitabine activated caspase-3 which leads to apoptosis or necrosis. However, 5-FU acted much more powerful than capecitabine at inducing several cytotoxicity markers in heart cardiomyocytes. In addition, 5-FU but not capecitabine caused lysosomal membrane leakiness when it was incubated with cardiomyocytes. All cytotoxicity markers were prevented by antioxidants, ROS scavengers, mitochondrial permeability transition (MPT) pore sealing agents and lysosomotropic agents.</p> <p>3. Our findings showed that the cytotoxic action of 5-FU and capecitabine on cardiomyocytes are mediated by oxidative stress and subsequent mitochondrial dysfunction which causes caspase-3 activation and cell death.</p> </abstract> … (more)
- Is Part Of:
- Xenobiotica. Volume 45:Number 1(2015:Jan.)
- Journal:
- Xenobiotica
- Issue:
- Volume 45:Number 1(2015:Jan.)
- Issue Display:
- Volume 45, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 45
- Issue:
- 1
- Issue Sort Value:
- 2015-0045-0001-0000
- Page Start:
- 79
- Page End:
- 87
- Publication Date:
- 2015-01
- Subjects:
- Metabolism -- Periodicals
Drugs -- Physiological effect -- Periodicals
Food additives -- Periodicals
Chemicals -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
Metabolism -- Periodicals
574.133 - Journal URLs:
- http://informahealthcare.com/journal/xen ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/00498254.2014.942809 ↗
- Languages:
- English
- ISSNs:
- 0049-8254
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9367.020000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4026.xml